|
ARHGEF11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.628800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.604600E-01 |
| Normal-vs-Stage2 |
3.133400E-01 |
| Normal-vs-Stage3 |
1.386420E-01 |
| Normal-vs-Stage4 |
2.014000E-01 |
| Stage1-vs-Stage2 |
1.631050E-01 |
| Stage1-vs-Stage3 |
6.552300E-02 |
| Stage1-vs-Stage4 |
5.465600E-01 |
| Stage2-vs-Stage3 |
6.048600E-01 |
| Stage2-vs-Stage4 |
1.305020E-01 |
| Stage3-vs-Stage4 |
1.211200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.407200E-01 |
| Normal-vs-AfricanAmerican |
8.665000E-01 |
| Normal-vs-Asian |
9.122800E-01 |
| Caucasian-vs-AfricanAmerican |
8.456200E-01 |
| Caucasian-vs-Asian |
8.040400E-01 |
| AfricanAmerican-vs-Asian |
8.544800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.954000E-01 |
| Normal-vs-Female |
7.109500E-02 |
| Male-vs-Female |
7.756100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.155000E-01 |
| Normal-vs-Extreme_Weight |
8.780800E-01 |
| Normal-vs-Obese |
2.761000E-01 |
| Normal-vs-Extreme_Obese |
9.952400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.216200E-01 |
| Normal_Weight-vs-Obese |
2.750800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.005600E-01 |
| Extreme_Weight-vs-Obese |
2.413800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.470000E-01 |
| Obese-vs-Extreme_Obese |
5.948000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.886100E-02 |
| Normal-vs-Age(41-60Yrs) |
9.446000E-02 |
| Normal-vs-Age(61-80Yrs) |
7.273400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.423500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.744600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.447700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.376370E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.042100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.894500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.578400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.892000E-01 |
| Normal-VS-Type2 PRCC |
3.379400E-01 |
| Normal-VS-KIRP CIMP |
7.849000E-01 |
| Normal-VS-Unclassified PRCC |
1.610260E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.394400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.730400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.690500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.198000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.895800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.479400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.856600E-01 |
| Normal-vs-N1 |
1.637800E-01 |
| Normal-vs-N2 |
5.699800E-01 |
| N0-vs-N1 |
7.344300E-02 |
| N0-vs-N2 |
4.632800E-01 |
| N1-vs-N2 |
7.223000E-01 |
|
|
